# TargAnox

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/targanox

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.targanox.com
- Total disclosed funding: $5.1M
- Latest round: Series A (Mar 30, 2009)
- Investors on record: 2

## About

TargAnox is a domain name sales and leasing company, offering innovative solutions for clients to establish their digital presence. Their primary product, the targanox.com domain, features flexible purchasing options.Founded in 2008 and headquartered in Cambridge, US, TargAnox specializes in domain name sales and leasing. The company has secured funding through a Series A round led by Ascent Biomedical Ventures in March 2009, raising USD 5.1 mn. The company's founder has a history of entrepreneurial ventures, although specific details about previous companies are not disclosed.Targanox.com specializes in the sale and leasing of domain names, with a primary offering centered around its flagship domain, targanox.com, priced at USD 1,999. Customers can opt for either a full payment or a 'Lease to Own' plan, enabling them to pay USD 100 per month. This service caters to a broad market, including entrepreneurs and larger organizations, primarily in North America and Europe, ensuring secure transactions and localized currency options at checkout.Targanox.com generates revenue through the direct sale of domain names and the Lease to Own payment structure. The Lease to Own plan creates a recurring revenue stream as customers commit to monthly payments, allowing access to premium domain names without immediate full payment. Secure payment processing enhances customer confidence. Their pricing strategy includes immediate purchase options and flexible plans, positioning Targanox.com effectively within the domain marketplace.In March 2009, TargAnox raised USD 5.1 mn in Series A financing to support its growth initiatives. The company plans to expand its product offerings and enhance the user experience for domain acquisition. Future projects include developing additional domain names and exploring new markets for domain registration and leasing, particularly targeting areas in Europe and North America by 2025. The funding will be utilized to bolster marketing efforts and improve the technological infrastructure to facilitate these expansions.

## Funding rounds

- Series A, Mar 30, 2009, $5.1M — Ascent Biomedical Ventures, Mass General Brigham Ventures

## Investors

- Ascent Biomedical Ventures (https://capitalatlas.ai/funds/ascent-biomedical-ventures) — Series A
- Mass General Brigham Ventures (https://capitalatlas.ai/funds/mass-general-brigham-ventures) — Series A